01498.HK
PuraPharm Corporation Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.24
−2.40%Margins
Gross margin
54.6%
EBITDA margin
7.0%
EBIT margin
-4.7%
Net margin
-8.6%
FCF margin
-8.3%
-22.1%
Return on equity
-4.0%
Return on assets
-3.1%
Return on invested capital
0.46x
Asset turnover
-HKD 25.2M
Cash from operations
HKD 0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026